The effect of fresh whole milk without pasteurization or other pretreatment on in vitro antibacterial activity of selected compounds was determined in broth dilution. The milk was collected by hand directly from dairy goats, or by syringe or cannula from bovine quarters showing low bacterial counts. Antibacterial activity was determined in 50% (v/v) milk-broth medium against sensitive mastitis-etiologic strains of Streptococcus agalactiae and Staphylococcus aureus. The indicator saJt 2,3, 5-triphenyltetrazolium chloride was incorporated in the milk broth medium to determine inoculum growth. Contaminant interference was circumvented through early as well as late readings and comparisons with uninoculated control tubes, with and without the test compounds. Application of the method with more than 75 compounds, including nitrofurans, antibiotics, and other chemicals uncovered marked degrees of milk interference. The method warrants routine use among preliminary screens to relate in vitro with in vivo observations of antimicrobial activity. Similar procedures may be used with serum, skim milk, or mastitis-milk media for separating effects due to protein, lipid, or other elements in product evaluation.
Few studies have been conducted to demonstrate the effect of milk on the antibacterial activity of compounds. The effect of milk on antibiotics has been reported by Marshall, Price, and their co-workers (8, 10, 11) , but these have involved agar diffusion media and pretreated (autoclaved, skim, methoxylated, or pasteurized) milk fractions. These and other investigators (3, 5-7, 9, 12) 100% fresh cow's or goat's milk-broth demonstrated similar maximal growth in broth and milkbroth media. Further experiments indicated no significant difference in MIC activity ratios with either caprine or bovine milk supplements, and goat's milk was selected for the study because it generally had minimal or no contaminant interference.
The results of subsequent experiments with compound 4 (Table 2) showed little or no difference in ratios taken from the early or late observations (up to 48 hr) when either fresh milk or serum supplements were added to the media. Readings made at 20 to 24 hr were employed routinely as shown in Table 3 , except when contamination interference required use of the 14-to 17-hr data. Good replicate agreement was also obtained unless this contamination was excep- Ag/ml of TTC were used routinely, therefore, and no instances of potentiation were observed from data compared with earlier primary-screen results or with a broth series of compound dilutions, without the TIC indicator. The antibiotic test findings in Table 3 are in general agreement with values reported by Price and his co-workers (10, 11) . Chlortetracycline activity against S. agalactiae was niinimally affected by the untreated milk, as compared to an 8-to 16-fold increase in the MIC value for S. aureus. Erythromycin, penicillin, and streptomycin showed similar differences in effect on the two test organisms with corresponding reductions of 2-as compared with 32-fold, 2-as compared with 4-fold, and 2-to 8-fold as compared with 8-to 16-fold, respectively. Effects on nitrofuran derivatives activity also varied, and milk or serum interference was not predictable from reported solubility data. Of special interest were the differential effects of milk and serum on the in vitro activity of quinazoline compounds no. 5-7. This suggests specific lipid, rather than protein, inhibition of the heterocycic derivatives, and studies are indicated to relate the finding with in vivo data.
Considered with other studies designed to correlate in vitro and in vivo antimicrobial activities, this method lends itself to routine use among preliminary screens for potential products, especially mastitis evaluation. In addition to comparisons with serum, further milk modifications may be studied, and effects due to pH change, micro-or macromolecules, leukocytes, or other elements, may be determined for better understanding of compound action.
